BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 28090649)

  • 1. The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems.
    Luzum JA; Pakyz RE; Elsey AR; Haidar CE; Peterson JF; Whirl-Carrillo M; Handelman SK; Palmer K; Pulley JM; Beller M; Schildcrout JS; Field JR; Weitzel KW; Cooper-DeHoff RM; Cavallari LH; O'Donnell PH; Altman RB; Pereira N; Ratain MJ; Roden DM; Embi PJ; Sadee W; Klein TE; Johnson JA; Relling MV; Wang L; Weinshilboum RM; Shuldiner AR; Freimuth RR;
    Clin Pharmacol Ther; 2017 Sep; 102(3):502-510. PubMed ID: 28090649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines.
    Pritchard D; Patel JN; Stephens LE; McLeod HL
    Am J Health Syst Pharm; 2022 Jun; 79(12):993-1005. PubMed ID: 35230418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquitous Pharmacogenomics (U-PGx): The Time for Implementation is Now. An Horizon2020 Program to Drive Pharmacogenomics into Clinical Practice.
    Cecchin E; Roncato R; Guchelaar HJ; Toffoli G;
    Curr Pharm Biotechnol; 2017; 18(3):204-209. PubMed ID: 28044932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence and resources to implement pharmacogenetic knowledge for precision medicine.
    Caudle KE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Relling MV; Klein TE
    Am J Health Syst Pharm; 2016 Dec; 73(23):1977-1985. PubMed ID: 27864205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability Between Clinical Pharmacogenetics Implementation Consortium (CPIC
    Blazy C; Ellingrod V; Ward K
    Front Pharmacol; 2022; 13():939313. PubMed ID: 35814245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC).
    Caudle KE; Dunnenberger HM; Freimuth RR; Peterson JF; Burlison JD; Whirl-Carrillo M; Scott SA; Rehm HL; Williams MS; Klein TE; Relling MV; Hoffman JM
    Genet Med; 2017 Feb; 19(2):215-223. PubMed ID: 27441996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Clinical Pharmacogenetics Implementation Consortium: 10 Years Later.
    Relling MV; Klein TE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Caudle KE
    Clin Pharmacol Ther; 2020 Jan; 107(1):171-175. PubMed ID: 31562822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges and Opportunities in Implementing Pharmacogenetic Testing in Clinical Settings.
    Chang WC; Tanoshima R; Ross CJD; Carleton BC
    Annu Rev Pharmacol Toxicol; 2021 Jan; 61():65-84. PubMed ID: 33006916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank population.
    Verma SS; Keat K; Li B; Hoffecker G; Risman M; ; Sangkuhl K; Whirl-Carrillo M; Dudek S; Verma A; Klein TE; Ritchie MD; Tuteja S
    J Transl Med; 2022 Nov; 20(1):550. PubMed ID: 36443877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process.
    Caudle KE; Klein TE; Hoffman JM; Muller DJ; Whirl-Carrillo M; Gong L; McDonagh EM; Sangkuhl K; Thorn CF; Schwab M; Agundez JA; Freimuth RR; Huser V; Lee MT; Iwuchukwu OF; Crews KR; Scott SA; Wadelius M; Swen JJ; Tyndale RF; Stein CM; Roden D; Relling MV; Williams MS; Johnson SG
    Curr Drug Metab; 2014 Feb; 15(2):209-17. PubMed ID: 24479687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomics Implementation at the National Institutes of Health Clinical Center.
    Sissung TM; McKeeby JW; Patel J; Lertora JJ; Kumar P; Flegel WA; Adams SD; Eckes EJ; Mickey F; Plona TM; Mellot SD; Baugher RN; Wu X; Soppet DR; Barcus ME; Datta V; Pike KM; DiPatrizio G; Figg WD; Goldspiel BR
    J Clin Pharmacol; 2017 Oct; 57 Suppl 10(Suppl 10):S67-S77. PubMed ID: 28921647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimated nationwide impact of implementing a preemptive pharmacogenetic panel approach to guide drug prescribing in primary care in The Netherlands.
    Bank PCD; Swen JJ; Guchelaar HJ
    BMC Med; 2019 Jun; 17(1):110. PubMed ID: 31196067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Personalised pharmacogenetics. Evidence-based guidelines and clinical application of pharmacogenetic diagnostics].
    Stingl JC; Brockmöller J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1509-21. PubMed ID: 24170080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A stepwise approach to implementing pharmacogenetic testing in the primary care setting.
    Weitzel KW; Duong BQ; Arwood MJ; Owusu-Obeng A; Abul-Husn NS; Bernhardt BA; Decker B; Denny JC; Dietrich E; Gums J; Madden EB; Pollin TI; Wu RR; Haga SB; Horowitz CR
    Pharmacogenomics; 2019 Oct; 20(15):1103-1112. PubMed ID: 31588877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardization can accelerate the adoption of pharmacogenomics: current status and the path forward.
    Caudle KE; Keeling NJ; Klein TE; Whirl-Carrillo M; Pratt VM; Hoffman JM
    Pharmacogenomics; 2018 Jul; 19(10):847-860. PubMed ID: 29914287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the Guidelines of the Clinical Pharmacogenetics Implementation Consortium and the Dutch Pharmacogenetics Working Group.
    Bank PCD; Caudle KE; Swen JJ; Gammal RS; Whirl-Carrillo M; Klein TE; Relling MV; Guchelaar HJ
    Clin Pharmacol Ther; 2018 Apr; 103(4):599-618. PubMed ID: 28994452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to Implement a Pharmacogenetics Service at your Institution.
    Cicali EJ; Lemke L; Al Alshaykh H; Nguyen K; Cavallari LH; Wiisanen K
    J Am Coll Clin Pharm; 2022 Nov; 5(11):1161-1175. PubMed ID: 36589694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomics implementation across multiple clinic settings: a qualitative evaluation.
    Shue SA; Rowe E; Bell LA; Damush T; DeLong A; Gowan T; Skaar T; Haggstrom D
    Pharmacogenomics; 2023 Nov; 24(17):881-893. PubMed ID: 37975236
    [No Abstract]   [Full Text] [Related]  

  • 19. Thoughtful Clinical Use of Pharmacogenetics in Child and Adolescent Psychopharmacology.
    Ramsey LB; Namerow LB; Bishop JR; Hicks JK; Bousman C; Croarkin PE; Mathews CA; Van Driest SL; Strawn JR
    J Am Acad Child Adolesc Psychiatry; 2021 Jun; 60(6):660-664. PubMed ID: 32860906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendations for pharmacogenetic testing in clinical practice guidelines in the US.
    Hertz DL; Bousman CA; McLeod HL; Monte AA; Voora D; Orlando LA; Crutchley RD; Brown B; Teeple W; Rogers S; Patel JN
    Am J Health Syst Pharm; 2024 Apr; ():. PubMed ID: 38652504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.